Physician profile
Angello Lin
NPI 1184647760
$1,396.65
in general payments reported to CMS, 2019-2025
16 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.79 · 2023: $277 · 2024: $627 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.87 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $257.53 | 2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $152.92 | 2024-2025 | Prevymis, Dificid |
| Inari Medical, INC. | $128.00 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $119.68 | 2024 | Cresemba |
| Acera Surgical, INC. | $109.55 | 2025 | Restrata Wound Matrix |
| Travere Therapeutics, INC. | $104.58 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $99.62 | 2025 | |
| Kci USA, INC. | $83.79 | 2019 | |
| Veloxis Pharmaceuticals, INC. | $80.70 | 2024-2025 | Envarsus |
| Takeda Pharmaceuticals U.S.A., INC. | $74.90 | 2024-2025 | Livtencity |
| Mallinckrodt Hospital Products INC. | $51.48 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $47.10 | 2025 | |
| Amgen INC. | $28.20 | 2025 | Krystexxa |
| Kyowa Kirin, INC. | $22.08 | 2024 | Crysvita |
| Lemaitre Vascular, INC. | $19.25 | 2023 | Artegraft Vascular Graft |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $17.27 | 2025 | Givlaari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angello Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.